Global Patient Blood Management Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Instruments(Blood Processing Devices[Centrifuges, and Blood Cell Processors], Blood Transfusion Devices[ Apheresis Machines, Plasma & Plasma Component Separators, Cell Salvage Systems, and Others], Blood Culture Screening Devices[Automated Blood Culture Systems, and Supporting Laboratory Equipment], Diagnostic & Testing Instruments[PCR Instruments, Hematology Analyzers, NGS Platforms, and Blood Grouping Analyzers], Blood Storage Devices[Medical Refrigerators, and Medical Freezers], Syringes & Needles, Vials & Tubes, Blood Bags, and Others), Reagents & Kits(Culture Media, Reagents, Kits, and Others), Software.

By Component;

Whole Blood, and Plasma.

By End User;

Blood Banks, Hospitals, Diagnostic Clinics, and Pathology Labs.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn327394487 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Patient Blood Management Market (USD Million), 2021 - 2031

In the year 2024, the Global Patient Blood Management Market was valued at USD 15,116.13 million. The size of this market is expected to increase to USD 23,376.25 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.

PBM focuses on optimizing the care of patients who might need transfusions, ensuring that blood transfusions are used appropriately, and employing strategies to minimize blood loss and maximize patient blood cell production. This approach not only enhances patient safety but also contributes to better clinical outcomes by reducing the risks associated with unnecessary transfusions, such as infections and immunological reactions. The rising prevalence of chronic diseases, increasing surgical procedures, and the growing awareness among healthcare providers about the benefits of PBM are further fueling market expansion.

Key components of the PBM market include blood conservation techniques, patient-specific blood management strategies, and advanced diagnostic technologies to monitor and manage patients’ hemoglobin levels effectively. These innovations are transforming the landscape of transfusion medicine, offering healthcare facilities opportunities to implement tailored approaches that align with individual patient needs and clinical protocols. Regulatory initiatives promoting evidence-based practices in blood management are shaping market dynamics globally, encouraging healthcare providers to adopt standardized protocols and guidelines. As the demand for efficient healthcare delivery continues to rise, coupled with the imperative to reduce healthcare costs, the Patient Blood Management market is poised for continued growth and innovation in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Component
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Patient Blood Management Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Development of targeted therapies reducing transfusions
        2. Integration of PBM into clinical guidelines
        3. Technological innovations in blood diagnostics
        4. Adoption of electronic health records
      2. Restraints
        1. Integration challenges in healthcare workflows
        2. Variability in patient response to PBM
        3. Concerns over efficacy of blood conservation devices
      3. Opportunities
        1. Improvement in blood conservation device safety
        2. Expansion of blood banks and donation networks
        3. Integration of genetic testing in PBM
        4. Enhanced interoperability of PBM software
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Patient Blood Management Market, By Product, 2021 - 2031 (USD Million)
      1. Instruments
        1. Blood Processing Devices
          1. Centrifuges
          2. Blood Cell Processors
        2. Blood Transfusion Devices
          1. Apheresis Machines
          2. Plasma & Plasma Component Separators
          3. Cell Salvage Systems
          4. Others
        3. Blood Culture Screening Devices
          1. Automated Blood Culture Systems
          2. Supporting Laboratory Equipment
        4. Diagnostic & Testing Instruments
          1. PCR Instruments
          2. Hematology Analyzers
          3. NGS Platforms
          4. Blood Grouping Analyzers
        5. Blood Storage Devices
          1. Medical Refrigerators
          2. Medical Freezers
        6. Syringes & Needles
        7. Vials & Tubes
        8. Blood Bags
        9. Others
      2. Reagents & Kits
        1. Culture Media
        2. Reagents
        3. Kits
        4. Others
        5. Software
    2. Global Patient Blood Management Market, By Component, 2021 - 2031 (USD Million)
      1. Whole Blood
      2. Plasma
    3. Global Patient Blood Management Market, By End User, 2021 - 2031 (USD Million)
      1. Blood Banks
      2. Hospitals
      3. Diagnostic Clinics
      4. Pathology Labs
    4. Global Patient Blood Management Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Biomrieux SA
      2. Bio-Rad Laboratories, Inc.
      3. Fresenius Se & Co. KGaA
      4. Danaher Corporation
      5. Hitachi, Ltd.
      6. Abbott Laboratories
      7. F. Hoffmann-La Roche LTD
      8. Terumo Corporation
      9. Stafa Cellular Therapy
      10. B. Braun Melsungen AG
  7. Analyst Views
  8. Future Outlook of the Market